OPKO granted patent from USPTO for RAYALDEE
OPKO announced that the USPTO granted OPKO a patent covering RAYALDEE™, the Company's product to treat secondary hyperparathyroidism in patients with stage 3 or 4 chronic kidney disease and vitamin D insufficiency. July 22, 2014